Edwin P M Jansen
Overview
Explore the profile of Edwin P M Jansen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
1491
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Claassen Y, de Steur W, Hartgrink H, Dikken J, van Sandick J, van Grieken N, et al.
Ann Surg
. 2017 Aug;
268(6):1008-1013.
PMID: 28817437
Objective: The purpose of this study was to evaluate surgicopathological quality and protocol adherence for lymphadenectomy in the CRITICS trial. Summary Of Background Data: Surgical quality assurance is a key...
22.
van der Kaaij R, Snaebjornsson P, Voncken F, van Dieren J, Jansen E, Sikorska K, et al.
Eur J Cancer
. 2017 Mar;
76:27-35.
PMID: 28262585
Aim: To investigate the histological subtypes of oesophageal adenocarcinoma according to the Laurén classification (intestinal/diffuse/mixed) in relation to tumour response to neoadjuvant treatment, and in relation to patients' survival after...
23.
Trip A, Stiekema J, Visser O, Dikken J, Cats A, Boot H, et al.
Acta Oncol
. 2015 Mar;
54(10):1754-62.
PMID: 25797568
Background: In recent years, evidence supporting multimodality treatment for oesophageal, oesophagogastric junction (OGJ), and gastric cancer has accumulated. This population-based cohort-study investigates trends and predictors of utilisation of multimodality treatment...
24.
Stiekema J, Trip A, Jansen E, Aarts M, Boot H, Cats A, et al.
Ann Surg Oncol
. 2014 Aug;
22(2):581-8.
PMID: 25164039
Objective: The aim of this study was to investigate the impact of adjuvant chemoradiotherapy (CRT) on survival of non-metastatic gastric cancer patients who had undergone an R1 resection. Methods: We...
25.
Trip A, Poppema B, van Berge Henegouwen M, Siemerink E, Beukema J, Verheij M, et al.
Radiother Oncol
. 2014 May;
112(2):284-8.
PMID: 24856116
Objectives: This study was initiated to investigate the feasibility and efficacy of preoperative radiotherapy with weekly paclitaxel and carboplatin in locally advanced gastric cancer. Methods: In a prospective study, patients...
26.
Dikken J, Coit D, Baser R, Gonen M, Goodman K, Brennan M, et al.
Int J Radiat Oncol Biol Phys
. 2014 Jan;
88(3):624-9.
PMID: 24411620
Purpose: The internationally validated Memorial Sloan-Kettering Cancer Center (MSKCC) gastric carcinoma nomogram was based on patients who underwent curative (R0) gastrectomy, without any other therapy. The purpose of the current...
27.
Stiekema J, Trip A, Jansen E, Boot H, Cats A, Balague Ponz O, et al.
Ann Surg Oncol
. 2013 Dec;
21(4):1107-14.
PMID: 24306660
Background: A microscopically irradical (R1) resection is a well-known adverse prognostic factor after gastric cancer surgery. However, the prognostic significance of an R1 resection in gastric cancer patients who are...
28.
Kruis M, Van de Kamer J, Sonke J, Jansen E, Van Herk M
Radiother Oncol
. 2013 Oct;
109(3):404-8.
PMID: 24094631
Purpose And Background: The purpose was to validate the accuracy of motion models derived from deformable registration from four-dimensional computed tomography (4DCT) and breath-hold contrast enhanced computed tomography (BHCCT) scans...
29.
Jansen E, Boot H, van de Velde C, Van Sandick J, Cats A, Verheij M
Recent Results Cancer Res
. 2012 Nov;
196:229-40.
PMID: 23129378
Surgical resection remains the essential part in the curative treatment of gastric cancer. However, with surgery only, long-term survival is poor (5-year survival <25 % in Europe). Randomized studies, which...
30.
Lutz M, Zalcberg J, Ducreux M, Ajani J, Allum W, Aust D, et al.
Eur J Cancer
. 2012 Aug;
48(16):2941-53.
PMID: 22921186
The 1st St. Gallen EORTC Gastrointestinal Cancer Conference 2012 Expert Panel clearly differentiated treatment and staging recommendations for the various gastroesophageal cancers. For locally advanced gastric cancer (≥T3N+), the preferred...